DCF Advisers’s Zimmer Biomet ZBH Stock Holding History

DCF Advisers’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.76M	Hold	30,500	–	–	0.74%	32
2025 Q4	$2.74M	Hold	30,500	–	–	0.74%	37
2025 Q3	$3M	Sell	30,500 -150	-0.5%	-$14.9K	0.97%	32
2025 Q2	$2.8M	Buy	30,650 +3,846	+14%	+$372K	1.3%	31
2025 Q1	$3.03M	Buy	26,804 +3,985	+17%	+$426K	1.45%	24
2024 Q4	$2.41M	Sell	22,819 -500	-2%	-$53.6K	1.17%	26
2024 Q3	$2.52M	Buy	23,319 +1,600	+7%	+$175K	1.01%	24
2024 Q2	$2.36M	Hold	21,719	–	–	1.21%	24
2024 Q1	$2.87M	Buy	21,719 +3,322	+18%	+$415K	1.41%	20
2023 Q4	$2.24M	Hold	18,397	–	–	1.22%	23
2023 Q3	$2.06M	Hold	18,397	–	–	1.12%	26
2023 Q2	$2.68M	Buy	+18,397	New	+$2.5M	1.42%	19

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DCF Advisers's ZBH Position: Q1 2026 in Review

DCF Advisers held its Zimmer Biomet (ZBH) position steady in Q1 2026 at 30,500 shares worth $2.76M. The position accounts for 0.74% of the portfolio, ranked #32.

DCF Advisers first reported a position in ZBH in Q2 2023 and has held it in 12 quarters since. The position peaked at $3.03M in Q1 2025. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

DCF Advisers held 30,500 shares of Zimmer Biomet worth $2.76M as of Q1 2026.
DCF Advisers left its Zimmer Biomet share count unchanged in Q1 2026.
Zimmer Biomet made up 0.74% of DCF Advisers's portfolio in Q1 2026, its #32 holding.
DCF Advisers first reported a position in Zimmer Biomet in Q2 2023 and has held it in 12 quarters since.
DCF Advisers's Zimmer Biomet position peaked at $3.03M in Q1 2025.
912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on DCF Advisers's 13F filing for Q1 2026, filed 11 May 2026.